{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20171212",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "50677",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125526s004lbl.pdf",
              "date": "20171213",
              "type": "Label"
            },
            {
              "id": "50750",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/125526Orig1s004ltr.pdf",
              "date": "20171218",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20170216",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "47264",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125526s002lbl.pdf",
              "date": "20170217",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "18",
          "submission_status": "AP",
          "submission_status_date": "20210729",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "68250",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/761122Orig1s006; 125526Orig1s018ltr.pdf",
              "date": "20210802",
              "type": "Letter"
            },
            {
              "id": "68267",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761122s006,125526s018lbl.pdf",
              "date": "20210802",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20151104",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "39988",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125526Orig1s000Lbl.pdf",
              "date": "20151105",
              "type": "Label"
            },
            {
              "id": "51328",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/125256 mepolizumab clinical prea.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            },
            {
              "id": "51329",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/125526 mepolizumab clinpharm prea.pdf",
              "date": "20180122",
              "type": "Pediatric Clinical Pharmacology Review"
            },
            {
              "id": "51330",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/125526 mepolizumab clinpharm addendum prea.pdf",
              "date": "19000101",
              "type": "Pediatric Clinical Pharmacology Addendum"
            },
            {
              "id": "51331",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/125526 mepolizumab statistical prea.pdf",
              "date": "19000101",
              "type": "Pediatric Statistical Review"
            },
            {
              "id": "64657",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/447_761122_mepolizumab unireview prea.pdf",
              "date": "19000101",
              "type": "Pediatric Other"
            },
            {
              "id": "9779",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/125526Orig1s000Ltr.pdf",
              "date": "20151105",
              "type": "Letter"
            },
            {
              "id": "22821",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/125526Orig1s000TOC.html",
              "date": "20151211",
              "type": "Review"
            },
            {
              "id": "24379",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/125526Orig1s000SumR.pdf",
              "date": "20151211",
              "type": "Summary Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "12",
          "submission_status": "AP",
          "submission_status_date": "20190912",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "59992",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/125526Orig1s012, 761122Orig1s002,s003ltr.pdf",
              "date": "20190913",
              "type": "Letter"
            },
            {
              "id": "60000",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125526s012,761122s002s003lbl.pdf",
              "date": "20190913",
              "type": "Label"
            },
            {
              "id": "63140",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/498_125526S12 mepolizumab multidisciplinary prea.pdf",
              "date": "19000101",
              "type": "Pediatric Other"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20250522",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "82311",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/125526Orig1s007ltr.pdf",
              "date": "20250527",
              "type": "Letter"
            },
            {
              "id": "82416",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/125526s007lbl.pdf",
              "date": "20250602",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "19",
          "submission_status": "AP",
          "submission_status_date": "20220122",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "69957",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/125526Orig1s019; 761122Orig1s008ltr.pdf",
              "date": "20220125",
              "type": "Letter"
            },
            {
              "id": "69974",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761122s008,125526s019lbl.pdf",
              "date": "20220126",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "17",
          "submission_status": "AP",
          "submission_status_date": "20200925",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "64696",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125526s017lbl.pdf",
              "date": "20200928",
              "type": "Label"
            },
            {
              "id": "64735",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/125526Orig1s017ltr.pdf",
              "date": "20200929",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "21",
          "submission_status": "AP",
          "submission_status_date": "20230308",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "73774",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125526Orig1s021,761122Orig1s011Corrected_lbl.pdf",
              "date": "20230316",
              "type": "Label"
            },
            {
              "id": "73786",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/125526Orig1s021;761122Orig1s011Corrected_ltr.pdf",
              "date": "20230317",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "13",
          "submission_status": "AP",
          "submission_status_date": "20190606",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "58986",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125526s013lbl.pdf",
              "date": "20190607",
              "type": "Label"
            },
            {
              "id": "58992",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/125526Orig1s013ltr.pdf",
              "date": "20190607",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "BLA125526",
      "sponsor_name": "GLAXOSMITHKLINE LLC",
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "NUCALA",
          "active_ingredients": [
            {
              "name": "MEPOLIZUMAB",
              "strength": "100MG"
            }
          ],
          "dosage_form": "INJECTABLE",
          "route": "SUBCUTANEOUS LYOPHILIZED POWER",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}